Rayovac 2010 Annual Report Download - page 128

Download and view the complete annual report

Please find page 128 of the 2010 Rayovac annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 190

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190

SPECTRUM BRANDS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In thousands, except per share amounts)
The fair value of outstanding derivative contracts recorded as assets in the accompanying Consolidated
Statements of Financial Position were as follows:
Asset Derivatives
September 30,
2010
September 30,
2009
Derivatives designated as hedging instruments under
ASC 815:
Commodity contracts .......................... Receivables—Other $2,371 $2,861
Commodity contracts .......................... Deferred charges and other 1,543 554
Foreign exchange contracts ..................... Receivables—Other 20 295
Foreign exchange contracts ..................... Deferred charges and other 55
Total asset derivatives designated as hedging
instruments under ASC 815 ............... $3,989 $3,710
Derivatives not designated as hedging
instruments under ASC 815:
Foreign exchange contracts ................. Receivables—Other — 75
Total asset derivatives ......................... $3,989 $3,785
The fair value of outstanding derivative contracts recorded as liabilities in the accompanying Consolidated
Statements of Financial Position were as follows:
Liability Derivatives
September 30,
2010
September 30,
2009
Derivatives designated as hedging instruments under
ASC 815:
Interest rate contracts ....................... Accounts payable $ 3,734
Interest rate contracts ....................... Accrued interest 861
Interest rate contracts ....................... Other long term liabilities 2,032
Foreign exchange contracts .................. Accounts payable 6,544 1,036
Foreign exchange contracts .................. Other long term liabilities 1,057
Total liability derivatives designated as hedging
instruments under ASC 815 .................... $14,228 $1,036
Derivatives not designated as hedging instruments
under ASC 815:
Foreign exchange contracts .................. Accounts payable 9,698 131
Foreign exchange contracts .................. Other long term liabilities 20,887
Total liability derivatives .................... $44,813 $1,167
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the
gain or loss on the derivative is reported as a component of AOCI and reclassified into earnings in the same
period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative
representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are
recognized in current earnings.
118